Phase 3 Study of ALZ-801 in APOE4/4 Early AD Subjects

Condition:   Early Alzheimer's Disease Interventions:   Drug: Experimental: ALZ-801;   Drug: Placebo Comparator: Placebo Sponsors:   Alzheon Inc.;   National Institute on Aging (NIA) Not yet recruiting

Source: ClinicalTrials.gov - February 25, 2021 Category: Research Source Type: clinical trials